Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum
Identification
- Public canonical key
- radar:r-08e7650e9c34d89d82d0e9036eaa0190
- Authors
- Baixun He · Jie Fu · Chong Chen · Wenxin Zhang · Shuang Li · Cherie S. Tan · Dong Ming
- Reported year
- 2025
- Reported language
- en
- Source type
- article
- First detected
- 2026-11-14T02:03:29.550623+00:00
- Last metadata observation
- 2026-11-14T02:03:29.550623+00:00
- Last HTTP verification
- Not checked
Institutions reported by the source
Tianjin University · Nankai University · Tianjin Medical University Cancer Institute and Hospital
Reported affiliation countries
CN
Documentary abstract — original language
The target neutrophil-activating peptide-2, NAP2, is a potential biomarker for early lung cancer diagnosis, whereas there are currently no precise techniques for differentiating NAP2 from its precursors. To overcome this difficulty, we created an electrochemical aptamer-based sensor (E-AB) consisting of the 33-mer aptamer domain, a 2-bp three-junction region, and two conductive signal reporter stems. Whereas E-AB-AT and E-AB-RAN sensors with two (AT) 6 or N 12 stems, respectively, were unable to distinguish between platelet basic protein (PBP) (94 aa) and NAP2 (70 aa). However, in contrast, the E-AB-GC sensor with two (GC) 6 stems could selectively detect NAP2 but hardly recorded PBP. Here, we developed an E-AB-GC point-of-care test (POCT) technique to detect NAP2 away from its precursors in 10 μL of human serum and provide concentration data in 5 min. Interestingly, serum NAP2 levels in human samples, as determined by the E-AB-GC sensor, were roughly 30–50% lower than those obtained by ELISA. Results also showed that E-AB-GC analysis of serum NAP2 in patients in stages I through IV revealed statistical significance and an excellent guiding function in the early diagnosis of lung cancer, particularly for patients in stage I cancer ( p = 0.0054, area under the curve, 0.95). Importantly, this E-AB-GC POCT platform has shown potential as an on-site quick diagnostic tool, which can also be used to detect other lung cancer markers. Our research on the impacts of stem sequencing on sensing capabilities might assist in the future development of E-AB biomarker sensors.
Identifiers
- OPENALEX
- https://openalex.org/W4409381364
- DOI
- 10.1021/acs.analchem.4c06815
- PMID
- https://pubmed.ncbi.nlm.nih.gov/40215095
Documentary context
- Documentary family
- article
- Source-reported types
- article
- Publishers
- American Chemical Society
Entity mentions are not evidence of legal recognition. Jurisdiction studied is separate from author affiliation country.
Sources
OpenAlex · Record 1
Cite this reference
Baixun He; Jie Fu; Chong Chen; Wenxin Zhang; Shuang Li; Cherie S. Tan; Dong Ming. Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. 2025. https://doi.org/10.1021/acs.analchem.4c06815
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690: bibliographic formats using available fields. OSCOLA / Bluebook: structured data only; full legal citation compliance is not claimed without verification of required elements.
- APA
- Baixun He; Jie Fu; Chong Chen; Wenxin Zhang; Shuang Li; Cherie S. Tan; Dong Ming. (2025). Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. https://doi.org/10.1021/acs.analchem.4c06815
- Chicago
- Baixun He; Jie Fu; Chong Chen; Wenxin Zhang; Shuang Li; Cherie S. Tan; Dong Ming. Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. 2025. https://doi.org/10.1021/acs.analchem.4c06815
- ISO 690
- Baixun He; Jie Fu; Chong Chen; Wenxin Zhang; Shuang Li; Cherie S. Tan; Dong Ming. Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. 2025. https://doi.org/10.1021/acs.analchem.4c06815
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR Global Rights of Nature Legal Library. Early-Stage Lung Cancer Diagnosis by a Point-of-Care Electrochemical Aptamer-Based Sensor of NAP2 in Human Serum. Documentary record: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-08e7650e9c34d89d82d0e9036eaa0190/ · Last HTTP verification: not performed
Research dossiers and documentary relations
Source roles
Bibliographic / original publication source · https://doi.org/10.1021/acs.analchem.4c06815
An authority link alone does not verify a legal claim. Abstracts and full texts remain subject to their source terms.
Documentary status
Relevance pending
Library
This identity is not yet included in the Legal Library.